Mirati Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Mirati Therapeutics is scheduled to report earnings on February 27, 2024, and the estimated EPS forecast is €-2.41. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 16.40M	$ 13.37M	$ 7.17M	$ 934.00K	$ 5.43M
Gross Profit	$ 16.40M	$ 13.69M	$ 7.17M	$ 934.00K	-
EBIT	$ -161.90M	$ -174.35M	$ -184.59M	$ -202.22M	$ -186.44M
EBITDA	$ -160.79M	$ -173.24M	$ -183.51M	$ -201.33M	$ -185.73M
Net Income Common Stockholders	$ -158.53M	$ -176.91M	$ -184.59M	$ -202.47M	$ -173.56M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 976.43M	$ 779.43M	$ 902.29M	$ 1.08B	$ 1.20B
Total Assets	$ 1.13B	$ 915.02M	$ 1.03B	$ 1.20B	$ 1.30B
Total Debt	$ 42.20M	$ 42.72M	$ 43.23M	$ 43.66M	$ 51.26M
Net Debt	$ -934.23M	$ -736.71M	$ -859.07M	$ -1.04B	$ -1.15B
Total Liabilities	$ 183.24M	$ 186.09M	$ 171.13M	$ 206.13M	$ 174.03M
Stockholders Equity	$ 946.47M	$ 728.95M	$ 862.63M	$ 996.52M	$ 1.13B
Cash Flow	-
Free Cash Flow	$ -143.75M	$ -132.12M	$ -190.45M	$ -129.61M	$ -139.05M
Operating Cash Flow	$ -143.71M	$ -131.40M	$ -190.18M	$ -128.80M	$ -137.81M
Investing Cash Flow	$ -62.19M	$ 15.53M	$ 195.15M	$ 59.30M	$ 13.95M
Financing Cash Flow	$ 334.70M	$ 3.84M	$ 1.73M	$ 5.92M	$ 157.10M

Currency in USD

Mirati Therapeutics Earnings and Revenue History

Income Statement >

Mirati Therapeutics Debt to Assets

Balance Sheet >

Mirati Therapeutics Cash Flow

Cash Flow >

Mirati Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing